Extracellular ATP is known to inhibit growth of various tumours by activating specific purinergic receptors (P2-receptors). Since the therapy of advanced oesophageal cancer is unsatisfying, new therapeutic approaches are mandatory. Here, we investigated the functional expression and potential antiproliferative effects of P2-purinergic receptors in human oesophageal cancer cells. Prolonged incubation of primary cell cultures of human oesophageal cancers as well as of the squamous oesophageal cancer cell line Kyse-140 with ATP or its stable analogue ATPgS dose-dependently inhibited cell proliferation. This was due to both an induction of apoptosis and cell cycle arrest. 
ATP and related compounds are widespread transmitters for extracellular communication in many cell types. By coupling to specific purinergic receptors ATP is involved in a large variety of cellular functions (Ralevic and Burnstock, 1998) . The classification of P2 purinergic receptors, first suggested by Burnstock in the late seventies (Burnstock, 1978) distinguished between two major classes of P2-purinoceptors, first ionotropic P2-receptors (P2X), which are ligand-gated receptors containing an intrinsic ion channel, and second metabotropic P2-receptors (P2Y), which belong to the superfamily of G-protein coupled receptors. This classification has recently been expanded (Barnard et al, 1994; Fredholm et al, 1997) to accommodate the results of cloning studies which revealed the existence of multiple subclasses of P2Y purinoceptors. While ionotropic P2X-receptors are mainly expressed in the nervous system, platelets and in smooth muscle cells, metabotropic P2Y-receptors are distributed in a large variety of tissues, including epithelial tissues of the gastrointestinal system (Dubyak and elMoatassim, 1993; Roman and Fitz, 1999) . P2Y-receptors mainly couple to G q/11 -proteins to activate phospholipase C. Upon activation phosphatidylinositolbisphosphate (PIP 2 ) is hydrolyzed leading to the generation of IP 3 (inositoltrisphosphate), which triggers calcium release from intracellular stores (SR/ER) (Lytton et al, 1991) . Depletion of intracellular calcium stores in turn induces calcium influx across the plasma membrane (Lytton et al, 1991) . This Ca 2+ -influx mechanism, which depends on an initial elevation of [Ca 2+ ] i , has been referred to as 'calcium release' activated calcium influx' or 'capacitative calcium entry' (Berridge, 1995) .
ATP is known to inhibit cancer growth in various tumour models (Rapaport, 1990; Haskell et al, 1996; Correale et al, 1997; Ishikawa et al, 1997) . ATP-induced apoptosis was in the past considered to be mediated by ionotropic P2-receptors only (Fredholm et al, 1994; Bronte et al, 1996; Correale et al, 1997) . However, there is growing evidence that by altering intracellular calcium concentrations metabotropic P2-receptors may be involved in both growth inhibition and programmed cell death (Fang et al, 1992; Duncan et al, 1996; McConkey and Orrenius, 1997; .
Oesophageal cancers have not been studied in this respect so far. Therefore we investigated the P2-receptor-mediated, cell cycle arresting and apoptosis inducing effects of extracellular nucleotides in oesophageal cancer cells.
MATERIALS AND METHODS

Materials
Fura-2/AM, gramicidin, ATP, ATPgS, UTP, ADP, UDP, 2-methylthio-ATP (2MeSATP), a,b-methylene-ATP (a,b-meATP) and adenosine were purchased from Sigma Chemicals Co. (Münch-en, Germany) . SBFI/AM and pluronic-F127 were purchased from Molecular Probes (Eugene OR, USA). RPMI 1640 was obtained from Biochrom-Seromed KG (Berlin, Germany). All stock solu-tions except from fura-2/AM, SBFI/AM and adenosine (solubilized in DMSO) were prepared in water and stored in aliquots of appropriate size at 7208C until use.
Cell culture
The human oesophageal squamous carcinoma cell line Kyse-140 (Shimada et al, 1992) was maintained in standard RPMI 1640 medium, complemented with 10% foetal calf serum and was kept in an incubator (378C, 5% CO 2 humidified atmosphere).
Primary cell cultures of histologically verified oesophageal squamous cell carcinomas were established from endoscopic biopsies of seven oesophageal cancer patients (three female, four male patients, age: 52 -69 years). The human tumour material was used according to the standards set by the Ethical Committee of the Benjamin Franklin University Hospital, Free University of Berlin, Germany. Preparation was performed by mechanical dissection using an automated disaggregation system (Medimachine; Becton Dickinson, Heidelberg, Germany) as described elsewhere in detail . The isolated human oesophageal carcinoma cells were maintained in nutrient medium based on Earle's 199-medium (Biochrom, Berlin, Germany) complemented with 20% foetal calf serum, 2 mM L-glutamine, 2% (v/v) Biotect protectivemedium (Biochrom, Berlin, Germany), penicillin (100 U ml 71 ), streptomycin (100 mg ml 71 ), amphotericin B (1% v/v) and were kept in an incubator (378C, 5% CO 2 humidified atmosphere). Half of the medium was changed every second day. Cells remained in culture for at least 2 days before the experiments were carried out. Squamous epithelial origin of the isolated primary culture cells was confirmed by immunostaining with a FITC-labelled cytokeratin antibody (cytokeratin/FITC clone MNF 116, DAKO, Hamburg, Germany).
Cell proliferation assay
Antiproliferative effects of a sustained application of P2-receptor agonists on human oesophageal carcinoma cells were studied by performing proliferation assays according to the crystal violet method (Gillies et al, 1986) . In brief, Kyse-140 cells were seeded on 96-well plates at a density of 5000 cells per well. ATP, ATPgS, 2MeSATP or adenosine were added in concentrations from 100 to 500 mM. If stated, cells were additionally treated with 10 or 100 mM of the ecto-ATPase inhibitor ARL 67156 (6-N,Ndiethyl-b-g-dibromomethylene-D-adenosine-5'-triphosphate trisodium; RBI, Natick, MA, USA) which was given 1 h before as well as during nucleotide incubation. Each concentration group consisted of 10 wells. The incubation medium was changed daily. Cells of each well were washed with phosphate-buffered saline (PBS) and fixed with 100 ml glutaraldehyde (1% v/v) in PBS for 15 min at room temperature. After another washing step cells were stained with 0.1% crystal violet in PBS for 30 min at room temperature. The unbound dye was removed by washing with H 2 O for 30 min. Crystal violet which had absorbed onto the cells was solubilized with 100 ml Triton X-100 (0.2%) in PBS for at least 24 h at 378C. The crystal violet coloured solution was spectrophotometrically measured at 570 nm using an ELISA-Reader. In the range between 500 to 100 000 cells per well the measured extinction was linear to the number of cells.
Cell cycle analysis
Cell cycle analysis was performed by using the method of Vindelov and Christensen (1990) . 5610 5 cells per well were cultured for 24 h and then exposed to the respective nucleotide for another 24 h. Cells were trypsinized, washed, and the nuclei were isolated using CycleTest PLUS DNA Reagent Kit (Becton Dickinson, Heidelberg, Germany). DNA was stained with propidium iodide according to the manufacturers' instructions. The DNA content of the nuclei was detected by flow cytometry and analyzed using CellFit software (Becton Dickinson, Heidelberg, Germany).
Caspase-3 activity assay
Cells were incubated with medium containing ATP or ATPgS at concentrations from 50 to 500 mM for 48 h, washed twice with PBS, and stored at 7808C until use. Approximately 10 6 cells were lysed with 500 ml lysis buffer (10 mM Tris-HCl, 10 mM NaH 2 PO 4 / Na 2 HPO 4 , 130 mM NaCl, 1% Triton X-100, 10 mM NaPP i , pH 7.5) and total protein content was quantified using the BCA protein assay kit (Pierce, Rockford, IL, USA). Caspase-3 activity was calculated from the cleavage of the fluorogenic substrate DEVD-AMC (Nicholson et al, 1995) . In brief, 100 ml cell lysate containing 500 mg ml 71 protein was incubated with 100 ml substrate solution (2 mg caspase-3 substrate AC-DEVD-AMC, 20 mM HEPES, 10% glycerol, 2 mM DTT, pH 7.5) for 1 h at 378C. Cleavage of DEVD-AMC was measured with a VersaFluor fluorometer (Biorad, Munich, Germany) using a 360 nm excitation and a 460 nm emission wavelength.
TUNEL assay
Determination of apoptosis specific DNA strand breaks was performed by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling (TUNEL) assay (Li et al, 1996) according to the manufacturers' instructions (Roche, Mannheim, Germany). Cells were fixed with 4% paraformaldehyde for 1 h at room temperature, washed once with 200 ml 1% BSA in PBS, followed by permeabilization with 0.1% Triton X-100 in 0.1% sodium citrate solution for 2 min on ice. After washing with 200 ml 1% BSA in PBS, cells were stained with 50 ml TUNEL reaction mixture (Roche, Mannheim, Germany) for 1 h at 378C in a humidified atmosphere in the dark. After two additional washing steps, nuclear fluorescence was analyzed using a Zeiss Axioskop-2 microscope.
Reverse transcriptase chain reaction (RT -PCR)
RNA isolation, reverse transcription and PCR reactions were carried out as described elsewhere in detail . Total RNA was isolated from cells using the RNeasy Kit (Qiagen, Valencia, CA, USA) according to the manufacturers' instructions. To eliminate any possible contamination with genomic DNA, RNAs were treated with 1 U DNAse I (Gibco, Karlsruhe, Germany) per mg RNA for 15 min at room temperature. Furthermore, possible contamination with genomic DNA was excluded by control experiments omitting the reverse transcriptase. Purified RNA was reverse transcribed into cDNA using the oligo-dT-primers and the SuperScript Preamplification-Kit (Gibco, Karlsruhe, Germany). PCR reactions were carried out in a total volume of 50 ml containing 400 nM of each primer, 200 mM of each dNTP (Pharmacia, Uppsala, Sweden), 50 mM KCl, 1.5 mM MgCl 2 , 10 mM Tris, and 1 Unit Taq-polymerase (Pharmacia, Uppsala, Sweden). PCR was performed in a Peltier-thermocycler (PTC-200, MJ-Research, USA) at the following conditions: Initial heating to 958C for 5 min, then 30 cycles at 958C for 30 s, 608C for 30 s for P2X-and P2Y 6 -primers, or 708C for 30 s for P2Y 1,2,4 -primers, or 638C for 1 min for b-actin primers, respectively, and 728C for 1 min, followed by a final elongation step of 7 min at 728C. Amplification of the cDNA sequences encoding for the tested human P2-receptor subtypes was performed using specific and established primer sequences (Schöfl et al, 1999; Yamamoto et al, 2000; Höpfner et al, 2001) as shown in Table 1 . The specificity of the cDNA products was additionally controlled by direct sequencing which was performed by Invitek Sequencing Service GmbH, Berlin-Buch, Germany. As a control for the amount of cDNA, RT -PCR was performed using b-actin primers (Table 1) .
Immunofluorescence labelling and fluorescence microscopy
Cells were washed with PBS, fixed by incubation with 4% paraformaldehyde in PBS for 30 min at room temperature, and washed again with PBS. Cells were then incubated for 3 h at room temperature with 5 mg ml 71 polyclonal rabbit-anti-human P2Y 2 antibody, which was kindly provided by Dr BK Kishore (Kishore et al, 2000) , or with 5 mg ml 71 polyclonal rabbit-anti-human P2Y 4 antibody Ab-1 (Oncogene, Cambridge, CA, USA). Thereafter cells were washed twice with PBS and incubated with 4 mg ml 71 secondary Alexa TM 488-labelled goat-anti-rabbit IgG antibody (Molecular Probes, Eugene, OR, USA) for 1 h at room temperature. Fluorescence and transmission images were obtained using a Zeiss Axioskop-2 microscope.
Measurement of intracellular calcium and sodium
Kyse-140 cells were grown on 25 mm glass coverslips coated with poly-L-lysine for improved attachment. For measurement of intracellular calcium cells were loaded with the fluorescent dye fura-2/ AM (5 mM) for 45 min at room temperature in a bath solution containing: 130 mM NaCl, 5.4 mM KCl, 1 mM CaCl 2 , 1 mM MgCl 2 , 10 mM glucose and 10 mM HEPES, adjusted to pH 7.3 with NaOH. The constituents of Ca 2+ -free solutions were the same as the bathing solution described above except that CaCl 2 was omitted and 0.1 mM EGTA was added to eliminate possible Ca 2+ -contaminations of the other constituents. Fluorescence measurements were performed at room temperature with a digital imaging system of T.I.L.L. Photonics (München, Germany) Höpfner et al, 1998) . Fura-2 fluorescence was excited alternatively at 340 and 380 nm with a monochromator provided by a 75 W xenon lamp. Cellular fluorescence was filtered through a 510 nm band pass filter. Images were digitalized and analyzed by FUCAL 5.12c software of T.I.L.L. Photonics. Ratio images were generated either at 1.5 or 2 s intervals. To compensate for background noise illumination of a cell-free area was subtracted. The calculation of the fura-2 signal was done as described in detail elsewhere (Morgan and Thomas, 1999 Changes in intracellular sodium concentration were monitored by loading the cells with the fluorescent dye SBFI/AM (10 mM) for 2 h at 378C, 5% CO 2 humidified atmosphere in the same bath solution as described above. For better dispersion of the dye in the loading medium the nonionic and nondenaturing detergent pluronic F-127 (0.04% (w/v)) was added. To remove extracellular remainders of SBFI/AM, the cells were washed three times in bath solution. Then the samples were kept in bath solution for at least 20 min to ensure complete intracellular de-esterafication of the dye. Fluorescence recordings with SBFI-loaded cells were performed under the same conditions as described above for fura-2, except from the excitation wavelength of the Na + -bound dye which was 344 nm. The data are represented as changes in 344/380 nm (DF344/F380 nm) fluorescence ratio, which is proportional to [Na + ] i .
Statistical analysis
Comparison of multiple means was performed with nonparametric ANOVA. Comparison of individual drug treatments to control treatments was performed using an unpaired, two-tailed MannWhitney U-test for proliferation and caspase-3 activity experiments. Data are expressed as mean percentage of control+s.e.m. For cell cycle analysis the unpaired student t-test was used. P values were considered to be significant at 50.05.
RESULTS
Growth inhibitory effects of extracellular nucleotides on oesophageal cancer cells
ATP is known to inhibit cancer growth in various tumour models (Agteresch et al, 1999) . However, its role in growth control of human oesophageal cancer remains elusive. To investigate putative growth modulating effects of extracellular nucleotides in oesophageal carcinoma cells, cell proliferation assays were performed with Kyse-140 cells. For these experiments ATP, the hydrolysis resistant Experimental Therapeutics Growth inhibition of oesophageal cancer by extracellular nucleotides K Maaser et al ATP derivative ATPgS, adenosine, and 2MeSATP were used ( Figure  1A ). Both ATP and ATPgS dose-dependently decreased cellular proliferation. The poorly hydrolysable ATPgS was even more effective (IC 50 =234+51 mM after 72 h of incubation) than ATP (IC 50 =450+31 mM). In contrast, 2MeSATP failed to inhibit the growth of Kyse-140 cells even at a concentration of 500 mM. Adenosine, the major breakdown product of ATP, showed no effects on cellular proliferation up to 250 mM. Only at the high adenosine concentration of 500 mM, mimicking the unlikely complete degradation of the maximal ATP-dose of 500 mM to adenosine, a growth inhibitory effect by adenosine of 24+6% was observed, presumably mediated by an activation of adenosine specific P1-receptors, which are ubiquitously expressed (Fang et al, 1992; Vandewalle et al, 1994) . However, the adenosine-evoked effect is about 50% less than those of ATP at the same concentration of ATP (52+6%). This means that even in case of a complete hydrolysis of ATP to adenosine, the antiproliferative effects of an ATP treatment can only be partially explained by an involvement of adenosine-mediated effects. Ecto-ATPases are membrane bound enzymes which dephosphorylate ATP, thereby terminating the stimulatory effects of ATP on P2-receptors. It has been shown by others that in several tissues the activation of ecto-ATPases themself is capable of altering intracellular second-messengers (e.g. NO) thereby also affecting cell growth (Sneddon et al, 2000) . To exclude a possible contribution of ecto-ATPases in the regulation of cell growth, the effects of the ecto-ATPase inhibitor ARL 67156 (10 -100 mM) were investigated. However, even 100 mM of the ecto-ATPase inhibitor ARL 67156 showed no significant influence on proliferation of Kyse-140 cells, thus excluding a contribution of ecto-ATPase signalling to the observed growth inhibitory effects (data not shown).
Effects of extracellular nucleotides on the cell cycle
To investigate if the observed growth inhibiting effects of extracellular nucleotides on oesophageal cancer cells were caused by cell cycle arrest, cell cycle analysis was performed. After sustained incubation of Kyse-140 cells with either ATP or ATPgS for 24 h a dose-dependent increase of the proportion of cells in the S-phase of the cell cycle was observed, indicating S-phase delay of the cells ( Figure 1B) . To exclude a possible contribution of breakdown products of ATP, in particular of adenosine, cell cycle analysis was performed with adenosine. In accordance with the proliferation data, adenosine (50 -500 mM) did not alter the regulation of the cell cycle (data not shown).
Apoptotic effects of extracellular nucleotides
To check whether the antiproliferative effects of ATP and ATPgS, respectively, were caused not only by cell cycle arrest but also by an induction of programmed cell death, the activation of caspase-3, a key-enzyme in the process of apoptosis, was investigated in Kyse-140 cells. After 48 h of incubation ATP dose-
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Cell number (% of control) dependently induced an increase of caspase-3 activity. With 500 mM ATP the caspase-3 activity was more than doubled compared to the untreated control (Figure 2A ). ATP-induced caspase-3 activity was not due to a generation of adenosine, since adenosine (50 -500 mM) failed to stimulate caspase-3 activity in Kyse-140 cells (data not shown). ATPgS did not affect caspase-3 activity ( Figure  2A ). Three to 72 h of incubation with rising concentrations of ATPgS (50 -500 mM) did not evoke significant effects on caspase-3 activity. To investigate a possible contribution of ecto-ATPasedependent generation of extracellular P i by degradation of ATP, which has already been shown to be involved in ATP-induced apoptosis (Zoeteweij et al, 1993) , we pre-incubated the cells with 100 mM of the ecto-ATPase-inhibitor ARL 67156. Under these conditions the ATP (500 mM for 48 h) evoked induction of caspase-3 activity decreased by 18+3.5% while ARL 67156 alone even increased caspase-3 activity by 28+16 %. The data suggest that ecto-ATPase dependent generation of extracellular P i is involved in ATP-induced apoptosis of oesophageal cancer cells. In primary oesophageal cancer cells induction of apoptosis by ATP was investigated by end-labelling of DNA with fluoresceindUTP (TUNEL assay). Fluorescence microscopy of primary cell cultures of oesophageal cancers treated with 500 mM ATP for 48 h revealed an increase in apoptosis specific DNA strand breaks of 32.7+13% above the untreated control which showed an average proportion of apoptotic cells of 9.6+1.4%. (Figure 2B ).
Expression of P2-receptor mRNA and protein
To elucidate which P2-receptor subtype(s) may be responsible for the growth inhibiting and apoptotic effects of extracellular nucleotides, the mRNA expression of ionotropic P2-receptors (P2X 1 , P2X 3 , P2X 4 , P2X 5 , and P2X 7 ) and metabotropic P2-receptors (P2Y 1 , P2Y 2 , P2Y 4 , and P2Y 6 ) was investigated by RT -PCR. Kyse-140 cells expressed mRNAs of P2X 4 -, P2X 5 -, and P2Y 2 -receptors ( Figure 3A) . Interestingly, no mRNA-expression of P2X 1 -or P2X 7 -receptors, which are mainly implicated in the induction of apoptosis (Chow et al, 1997; Di Virgilio et al, 1998; Ferrari et al, 1999) was observed. The mRNA of P2Y 2 -and P2X 4 receptors was also detected in biopsies of human squamous cancers of the oesophagus, while transcripts of P2X 1 and P2X 7 receptors were also missing in the mRNA of oesophageal cancer biopsies ( Figure 4A ).
The specificity of PCR was confirmed by direct sequencing of transcripts (data not shown).
However, using immunocytochemistry only a P2Y 2 -receptorspecific fluorescence was detected in the membrane of either Kyse-140 and primary culture cells ( Figure 3B,D) , whereas neither Kyse-140 cells nor primary cell culture preparations showed any specific staining for P2X 4 receptors ( Figure 3C ,E). Thus it is likely, that despite the mRNA expression of P2X 4 receptors no translation into P2X 4 protein occurs in the cells. Figure 4D ), indicating the expression of purine and pyrimidine-sensitive receptors in oesophageal cancer cells. Pre-treatment of the cells with 100 mM of either ATP or UTP prevented a second rise in [Ca 2+ ] i in response to a consecutive stimulation with the respective other nucleotide ( Figure 4C,D) . This complete homologous cross-desensitization between ATP and UTP indicates that both nucleotides were competitively acting on a common binding site. Since only one metabotropic P2Y-receptor equipotently activated by either ATP or UTP, is known so far, these data strongly suggest the functional expression of P2Y 2 -receptors in Kyse-140 cells.
Expression of functional P2-receptors
For further pharmacological characterization, a possible contribution of P2X-receptors to the observed changes in [Ca 2+ ] i was investigated by using the P2X-receptor specific agonists 2-methylthio-ATP (2MeSATP) and a,b-methylene-ATP (a,bmeATP). P2Y 1 -, P2Y 11 -, P2Y ADP -and the ionotropic P2X 1 -6 -receptors have been shown to be sensitive for 2MeSATP (Lambrecht, 2000) . However, 100 mM 2MeSATP did not evoke any increase of [Ca 2+ ] i in Kyse-140 cells ( Figure 4E ). Even at the high concentration of 500 mM, 2MeSATP showed no [Ca 2+ ] i -inducing effects (data not shown). However, it has been shown by others (Weidema et al, 2001) (Figure 5 ). Comparable negative results were obtained by applying ATP or UTP (100 mM) (data not shown). As positive control the cells were treated with 10 mM gramicidin at the end of each experiment. Gramicidin is known to perforate the cell membrane to become sodium-permeable (Diarra et al, 2001) . Gramicidin treatment always led to an increase of [Na + ] i ( Figure 5 ). In line with the negative results of P2X 4 -immunocytochemistry our data suggest, that despite the mRNA expression of P2X 4 -receptors, neither protein nor functional P2X 4 receptor expression occurred in Kyse-140 cells.
As expected by the negative results of RT -PCR for the mRNAexpression of P2X 1 and P2X 7 receptors, no increase in [Ca 2+ ] i was observed when the cells were challenged by the P2X-receptor agonist a,b-meATP, which additionally excluded a contribution of these receptor subtypes in the observed apoptotic and cell cycle Experimental Therapeutics arresting effects on oesophageal cancer cells. To conclude, the rank order of potency of the applied nucleotides to increase [Ca 2+ ] i was ATP=UTP4ATPgS4ADP=UDP442MeSATP=a,b-meATP. This graded efficiency of different nucleotides to increase [Ca 2+ ] i reflects the pharmacological pattern of P2Y 2 -receptors, which thus seems to be the only functionally expressed P2-receptor subtype in squamous oesophageal cancer cells.
P2Y 2 -receptors couple to phospholipase C via G q/11 proteins (Burnstock, 1997) . To determine the role of phospholipase C in the signalling pathway of P2Y 2 -receptors in Kyse-140 cells, the specific phospholipase C inhibitor U73122 was used. U73122 dose-dependently inhibited the increase of [Ca 2+ ] i upon ATP stimulation at micromolar concentrations, whereas its inactive analogue U73343 showed little if any effect (Figure 6 ). Fifty mM U73122 completely suppressed the ATP induced [Ca 2+ ] i -rises, confirming that in Kyse-140 cells P2Y 2 -receptors couple to phospholipase C and thereby effect [Ca 2+ ] i -rises.
DISCUSSION
ATP is released from malignant cells in response to chemo-or radiotherapy. Extracellular ATP is known to inhibit growth of Ehrlich ascites tumour cells, colon cancer, ovarian cancer, endometrial cancer, breast cancer, and fibroblast cell lines (Estrela et al, 1995; Correale et al, 1997; Höpfner et al, 1998; Katzur et al, 1999; Li et al, 2000; Schultze-Mosgau et al, 2000) . Here we provide evidence that extracellular nucleotides induce apoptosis and cause cell cycle arrest in human squamous cancer cells of the oesophagus. ATP and ATPgS induced a delay in the S-phase of the cell cycle. The cell cycle arresting effects of extracellular nucleotides were similar to the ones elicited by the cytostatic drugs 5-fluorouracil and cisplatin in oesophageal cancer cells (Yamane et al, 1999; Mastbergen et al, 2000) . Moreover, for breast and ovarian cancer a positive correlation between S-phase fraction and the response to anticancer agents has recently been documented (Chevillard et al, 1996; Kolfschoten et al, 2000) . Hence, recruitment of cancer cells to the S-phase of the cell cycle by ATP might sensitise oesophageal cancer cells to a reinforced response to established chemotherapeutic drugs. Furthermore, cyclin-dependent kinase inhibitors such as flavopiridol, a promising new class of anticancer drugs, showed enhanced cytotoxity at cells arrested in the S-phase (Shapiro and Harper, 1999) . Hence, in addition to the antiproliferative action of ATP on its own, possible synergistic effects of ATP and anticancer drugs will be interesting to investigate. Accordingly, a synergistic antiproliferative effect of 5-FU and extracellular ATP Experimental Therapeutics has recently been described in colorectal carcinoma cells .
Besides its cell cycle interfering effects, ATP was shown to induce apoptosis in oesphageal cancer cells as assessed by TUNEL assays and measuring increases of caspase-3 activity. Both primary cell cultures and Kyse-140 cells were shown to undergo apoptosis upon ATP treatment. The ability of ATP to induce apoptosis via P2-receptors in a [Ca 2+ ] i -dependent manner has been formerly demonstrated by others (Chow et al, 1997) . On the other hand, using the hydrolysis resistant ATP derivative ATPgS, Katzur et al (1999) observed P2Y 2 -mediated antiproliferative but not apoptosis inducing effects in endometrial carcinoma cells. In our study both nucleotides, ATP and the ATPgS, evoked rises of [Ca 2+ ] i , but only ATP induced apoptosis. This suggests that in addition to the P2Y 2 -receptor triggered [Ca 2+ ] i -increase other signalling pathways may mediate apoptosis of oesophageal cancer cells in response to ATP. Interestingly, Zoeteweij et al (1993) showed that in hepatocytes [Ca 2+ ] i -induced apoptosis after prolonged exposure to ATP was dependent on the generation of extracellular inorganic phosphate (P i ), which resulted from an ecto-ATPase mediated hydolysis of the applied extracellular ATP. Hence, inorganic phosphate might be an additional signal necessary to induce apoptosis in oesophageal cancer cells. Since ATP is hydrolyzed by ubiquitously expressed ecto-ATPases and ectonucleotidases, this could explain, why the hydrolysis resistant ATP derivative ATPgS, which is additionally known to be an effective ecto-ATPase-inhibitor (Chen and Lin, 1997) , failed to induce apoptosis specific caspase-3 activation in oesophageal cancer cells. This interpretation was supported by our finding that the ecto-ATPase-inhibitor ARL 67156, which diminished the generation of P i by inhibiting ATPdegradation, resulted in a reduced activation of ATP induced caspase-3 activity.
Antiproliferative as well as apoptosis inducing actions of extracellular nucleotides are thought to result from (prolonged) Experimental Therapeutics stimulation of functionally expressed P2-receptors. While antiproliferative effects of metabotropic P2Y-receptors have been documented in various tumour models (Fang et al, 1992; Vandewalle et al, 1994; Höpfner et al, 1998; Katzur et al, 1999; Schultze-Mosgau et al, 2000) , apoptosis inducing effects of P2Y-receptors have only been shown in MCF-7-breast cancer (Vandewalle et al, 1994) and colorectal carcinoma cells However, the main P2-receptor subtypes implicated in apoptosis are ionotropic P2X-receptors of the subtypes P2X 1 and P2X 7 (Chvatchko et al, 1996; Di Virgilio et al, 1998; Ferrari et al, 1999) . P2X-receptors are mainly found in excitable tissues such as smooth muscles and nerves, although P2X 4 -receptors have also been reported in endocrine tissues (Ralevic and Burnstock, 1998) . However, neither in primary cultures of oesophageal cancers nor in the oesophageal cancer cell line Kyse-140 mRNA expression of either P2X 1 -or P2X 7 -receptors could be detected. Only transcripts of the ionotropic P2-receptor subtypes P2X 4 and P2X 5 were found. So far neither P2X 4 nor P2X 5 has been implicated in the induction of apoptosis. Moreover, the functional expression of P2X 5 -receptors is most unlikely, since the human P2X 5 -receptors described are unable to form functional channels (North and Surprenant, 2000) . Nevertheless, to examine the possible expression and functionality of P2X 4 To ensure that the observed antiproliferative effects of extracellular nucleotides on oesophageal cancer cells were actually P2Y 2 -receptor mediated events and were not caused by unspecific effects of the applied nucleotides we also performed proliferation assays with the P2X 4 -receptor agonist 2MeSATP. Since we have excluded a functional expression of P2X 4 -receptors in the investigated oesophageal cancer cells and it is known that 2MeSATP does not activate P2Y 2 -receptors to a relevant extent (Ralevic and Burnstock, 1998) , only unspecific signalling of the applied nucleotide could yield antiproliferative effects. However, no contribution of 2MeSATP on the growth of oesophageal cancer cells could be observed -even at a concentration of 500 mM. These data suggest that the induction of growth inhibition and apoptosis in oesophageal cancer cells by extracellular ATP and ATPgS was caused by the activation of P2Y 2 -receptors, but was not due to unspecific effects of these extracellular nucleotides.
To conclude, our data show that extracellular nucleotides cause cell cycle arrest and induce apoptosis in human oesophageal carcinoma cells. These actions are mediated by P2Y 2 -receptors. Interestingly, ATP has already been studied as an anti-cachexia and antiproliferative agent in advanced lung-cancer (Haskell et al, 1996; Agteresch et al, 1999) . Taken together, we therefore think that P2Y 2 -receptors may qualify as promising targets for innovative treatment strategies of oesophageal cancer.
